A Study of LY3041658 in Participants With Skin Diseases

I7P-MC-DSAB -

The main purpose of this study is to investigate the safety and tolerability of the study drug known as LY3041658 in participants with certain types of skin diseases. The study will measure how the body absorbs, breaks down and gets rid of LY3041658.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
Psoriasis
What the trial is testing?
LY3041658
Could I receive a Placebo?
Yes
Enrollment Goal
60
Trial Dates
Nov 8, 2016 - Mar 19, 2019
How long will I be in the trial?
Your participation could last approximately 10 weeks and include 8 visits to the study center.
Trial Phase
I

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.